Calcineurin Inhibitor-Induced Type IV Renal Tubular Acidosis in Post-Bone Marrow Transplant: Review of Pathophysiology and Principles of Management

Calcineurin inhibitors (CNI) are the mainstay of immunosuppressant medications in both bone marrow transplants and solid organ transplants. Nephrotoxicity is a well-known adverse effect of this group. Type IV renal tubular acidosis is a potentially under-recognized complication. Here we report a cas...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2023-06, Vol.15 (6), p.e40215
Main Authors: Al-Omairi, Anwar, Abdulnasser Obaid, Mohammed, Agrawal, Indira, Abdalla, Amr, Al Rawas, Abdul Hakim
Format: Article
Language:English
Subjects:
Abdomen
Acidosis
Bone marrow
Case reports
Creatinine
Cytokines
Diet
Hematology
Hyperkalemia
Kidneys
Lymphocytes
Metabolism
Nephrology
Pathophysiology
Pediatrics
Pneumonia
Potassium
Sodium
Stem cell transplantation
T cell receptors
Urine
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c1825-30a5b32d8f4abeb2a8478d7e9dfb9a141ba3e49b32e70d7f1b15c9c97ab423b03
container_end_page
container_issue 6
container_start_page e40215
container_title Curēus (Palo Alto, CA)
container_volume 15
creator Al-Omairi, Anwar
Abdulnasser Obaid, Mohammed
Agrawal, Indira
Abdalla, Amr
Al Rawas, Abdul Hakim
description Calcineurin inhibitors (CNI) are the mainstay of immunosuppressant medications in both bone marrow transplants and solid organ transplants. Nephrotoxicity is a well-known adverse effect of this group. Type IV renal tubular acidosis is a potentially under-recognized complication. Here we report a case of Omenn syndrome in a patient who underwent a bone marrow transplant and developed type IV renal tubular acidosis while on treatment with cyclosporine.
doi_str_mv 10.7759/cureus.40215
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10332329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2844011353</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1825-30a5b32d8f4abeb2a8478d7e9dfb9a141ba3e49b32e70d7f1b15c9c97ab423b03</originalsourceid><addsrcrecordid>eNpVkU1vEzEQhi0EolXpjTOyxJUt_lq8ywWVCEqkVkQocLXGH5u42tiLvW6V38EfrktKVU4z0jzzvqN5EXpNyZmUbf_elORKPhOE0fYZOmb0Q9d0tBPPn_RH6DTna0IIJZIRSV6iIy4Fb1lLj9GfBYzGB1eSD3gZtl77OaZmGWwxzuL1fnJ4-Qv_cAFGvC66jJDwufE2Zp9x3VnFPDefY3D4ClKKt3idIORphDB_rGs33t3iOOAVzNs4bffZxzFu9hiCxavqafw0unxPXEGAjdu5ML9CLwYYszt9qCfo59cv68W35vL7xXJxftkY2rG24QRazZntBgHaaQadkJ2VrreD7oEKqoE70VfESWLlQDVtTW96CVowrgk_QZ8OulPRO2dNtU4wqin5HaS9iuDV_5Pgt2oTbxQlnDPO-qrw9kEhxd_F5Vldx5Lqq7JinRCEUt7ySr07UCbFnJMbHi0oUfcxqkOM6m-MFX_z9KxH-F9o_A4rXZ0R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844011353</pqid></control><display><type>article</type><title>Calcineurin Inhibitor-Induced Type IV Renal Tubular Acidosis in Post-Bone Marrow Transplant: Review of Pathophysiology and Principles of Management</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Al-Omairi, Anwar ; Abdulnasser Obaid, Mohammed ; Agrawal, Indira ; Abdalla, Amr ; Al Rawas, Abdul Hakim</creator><creatorcontrib>Al-Omairi, Anwar ; Abdulnasser Obaid, Mohammed ; Agrawal, Indira ; Abdalla, Amr ; Al Rawas, Abdul Hakim</creatorcontrib><description>Calcineurin inhibitors (CNI) are the mainstay of immunosuppressant medications in both bone marrow transplants and solid organ transplants. Nephrotoxicity is a well-known adverse effect of this group. Type IV renal tubular acidosis is a potentially under-recognized complication. Here we report a case of Omenn syndrome in a patient who underwent a bone marrow transplant and developed type IV renal tubular acidosis while on treatment with cyclosporine.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.40215</identifier><identifier>PMID: 37435251</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Abdomen ; Acidosis ; Bone marrow ; Case reports ; Creatinine ; Cytokines ; Diet ; Hematology ; Hyperkalemia ; Kidneys ; Lymphocytes ; Metabolism ; Nephrology ; Pathophysiology ; Pediatrics ; Pneumonia ; Potassium ; Sodium ; Stem cell transplantation ; T cell receptors ; Urine</subject><ispartof>Curēus (Palo Alto, CA), 2023-06, Vol.15 (6), p.e40215</ispartof><rights>Copyright © 2023, AL-Omairi et al.</rights><rights>Copyright © 2023, AL-Omairi et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023, AL-Omairi et al. 2023 AL-Omairi et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1825-30a5b32d8f4abeb2a8478d7e9dfb9a141ba3e49b32e70d7f1b15c9c97ab423b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2844011353/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2844011353?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37435251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Omairi, Anwar</creatorcontrib><creatorcontrib>Abdulnasser Obaid, Mohammed</creatorcontrib><creatorcontrib>Agrawal, Indira</creatorcontrib><creatorcontrib>Abdalla, Amr</creatorcontrib><creatorcontrib>Al Rawas, Abdul Hakim</creatorcontrib><title>Calcineurin Inhibitor-Induced Type IV Renal Tubular Acidosis in Post-Bone Marrow Transplant: Review of Pathophysiology and Principles of Management</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Calcineurin inhibitors (CNI) are the mainstay of immunosuppressant medications in both bone marrow transplants and solid organ transplants. Nephrotoxicity is a well-known adverse effect of this group. Type IV renal tubular acidosis is a potentially under-recognized complication. Here we report a case of Omenn syndrome in a patient who underwent a bone marrow transplant and developed type IV renal tubular acidosis while on treatment with cyclosporine.</description><subject>Abdomen</subject><subject>Acidosis</subject><subject>Bone marrow</subject><subject>Case reports</subject><subject>Creatinine</subject><subject>Cytokines</subject><subject>Diet</subject><subject>Hematology</subject><subject>Hyperkalemia</subject><subject>Kidneys</subject><subject>Lymphocytes</subject><subject>Metabolism</subject><subject>Nephrology</subject><subject>Pathophysiology</subject><subject>Pediatrics</subject><subject>Pneumonia</subject><subject>Potassium</subject><subject>Sodium</subject><subject>Stem cell transplantation</subject><subject>T cell receptors</subject><subject>Urine</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpVkU1vEzEQhi0EolXpjTOyxJUt_lq8ywWVCEqkVkQocLXGH5u42tiLvW6V38EfrktKVU4z0jzzvqN5EXpNyZmUbf_elORKPhOE0fYZOmb0Q9d0tBPPn_RH6DTna0IIJZIRSV6iIy4Fb1lLj9GfBYzGB1eSD3gZtl77OaZmGWwxzuL1fnJ4-Qv_cAFGvC66jJDwufE2Zp9x3VnFPDefY3D4ClKKt3idIORphDB_rGs33t3iOOAVzNs4bffZxzFu9hiCxavqafw0unxPXEGAjdu5ML9CLwYYszt9qCfo59cv68W35vL7xXJxftkY2rG24QRazZntBgHaaQadkJ2VrreD7oEKqoE70VfESWLlQDVtTW96CVowrgk_QZ8OulPRO2dNtU4wqin5HaS9iuDV_5Pgt2oTbxQlnDPO-qrw9kEhxd_F5Vldx5Lqq7JinRCEUt7ySr07UCbFnJMbHi0oUfcxqkOM6m-MFX_z9KxH-F9o_A4rXZ0R</recordid><startdate>20230610</startdate><enddate>20230610</enddate><creator>Al-Omairi, Anwar</creator><creator>Abdulnasser Obaid, Mohammed</creator><creator>Agrawal, Indira</creator><creator>Abdalla, Amr</creator><creator>Al Rawas, Abdul Hakim</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope></search><sort><creationdate>20230610</creationdate><title>Calcineurin Inhibitor-Induced Type IV Renal Tubular Acidosis in Post-Bone Marrow Transplant: Review of Pathophysiology and Principles of Management</title><author>Al-Omairi, Anwar ; Abdulnasser Obaid, Mohammed ; Agrawal, Indira ; Abdalla, Amr ; Al Rawas, Abdul Hakim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1825-30a5b32d8f4abeb2a8478d7e9dfb9a141ba3e49b32e70d7f1b15c9c97ab423b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abdomen</topic><topic>Acidosis</topic><topic>Bone marrow</topic><topic>Case reports</topic><topic>Creatinine</topic><topic>Cytokines</topic><topic>Diet</topic><topic>Hematology</topic><topic>Hyperkalemia</topic><topic>Kidneys</topic><topic>Lymphocytes</topic><topic>Metabolism</topic><topic>Nephrology</topic><topic>Pathophysiology</topic><topic>Pediatrics</topic><topic>Pneumonia</topic><topic>Potassium</topic><topic>Sodium</topic><topic>Stem cell transplantation</topic><topic>T cell receptors</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Omairi, Anwar</creatorcontrib><creatorcontrib>Abdulnasser Obaid, Mohammed</creatorcontrib><creatorcontrib>Agrawal, Indira</creatorcontrib><creatorcontrib>Abdalla, Amr</creatorcontrib><creatorcontrib>Al Rawas, Abdul Hakim</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Omairi, Anwar</au><au>Abdulnasser Obaid, Mohammed</au><au>Agrawal, Indira</au><au>Abdalla, Amr</au><au>Al Rawas, Abdul Hakim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calcineurin Inhibitor-Induced Type IV Renal Tubular Acidosis in Post-Bone Marrow Transplant: Review of Pathophysiology and Principles of Management</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2023-06-10</date><risdate>2023</risdate><volume>15</volume><issue>6</issue><spage>e40215</spage><pages>e40215-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Calcineurin inhibitors (CNI) are the mainstay of immunosuppressant medications in both bone marrow transplants and solid organ transplants. Nephrotoxicity is a well-known adverse effect of this group. Type IV renal tubular acidosis is a potentially under-recognized complication. Here we report a case of Omenn syndrome in a patient who underwent a bone marrow transplant and developed type IV renal tubular acidosis while on treatment with cyclosporine.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>37435251</pmid><doi>10.7759/cureus.40215</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2023-06, Vol.15 (6), p.e40215
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10332329
source Publicly Available Content Database; PubMed Central
subjects Abdomen
Acidosis
Bone marrow
Case reports
Creatinine
Cytokines
Diet
Hematology
Hyperkalemia
Kidneys
Lymphocytes
Metabolism
Nephrology
Pathophysiology
Pediatrics
Pneumonia
Potassium
Sodium
Stem cell transplantation
T cell receptors
Urine
title Calcineurin Inhibitor-Induced Type IV Renal Tubular Acidosis in Post-Bone Marrow Transplant: Review of Pathophysiology and Principles of Management
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A09%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calcineurin%20Inhibitor-Induced%20Type%20IV%20Renal%20Tubular%20Acidosis%20in%20Post-Bone%20Marrow%20Transplant:%20Review%20of%20Pathophysiology%20and%20Principles%20of%20Management&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Al-Omairi,%20Anwar&rft.date=2023-06-10&rft.volume=15&rft.issue=6&rft.spage=e40215&rft.pages=e40215-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.40215&rft_dat=%3Cproquest_pubme%3E2844011353%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1825-30a5b32d8f4abeb2a8478d7e9dfb9a141ba3e49b32e70d7f1b15c9c97ab423b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2844011353&rft_id=info:pmid/37435251&rfr_iscdi=true